Our venture companies receive the full backing of SPRIM. Working within the SPRIM family allows our investments to not only achieve funding, but leverage the global SPRIM organization to realize growth.
Digital Clinical Solutions
ObvioHealth is a Virtual Research Organization (VRO) leading the long-overdue digitization of health innovation.
Fibronostics is a discovery platform developing non-invasive, algorithm-based diagnostics to improve treatment outcomes, facilitate screening of specific diseases and help prognosis in various chronic conditions.
1nHealth is a digital platform designed to accelerate the advancement of health through subject recruitment innovation, matching the right patients to the right trial at the right time.
RegASK is a digital platform using natural language processing for answering regulatory questions about path-to-market and path-to-claims for product expansions into foreign markets.
Evid Science utilizes a well-developed cutting edge Artificial Intelligence to ensure their customers have timely access to the most up-to-date medical evidence.
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity.
AUM Biosciences is at the forefront of disrupting the drug development process in oncology, to deliver pioneering and affordable targeted drugs across a broad spectrum of cancers.
STALICLA is a clinical-stage biopharmaceutical company with a team of domain experts, drug developers, clinicians, data scientists and computational biologists working to create NDD precision medicine solutions.
Spexis AG (SIX:SPEX) is a clinical-stage, publicly-listed biopharmaceutical company focused on discovering and developing first-in-class macrocyclic molecules for rare diseases and cancer.
SPRIM Consulting is a complete product lifecycle, health-focused consulting agency, featuring an integrated service model to handle all stages of research and development in life sciences and human health.
Our venture companies receive the full backing of SPRIM. Working within the SPRIM family allows our investments to not only achieve funding, but leverage the global SPRIM organization to realize growth.
